

{"id":3783,"date":"2026-10-05T10:07:16","date_gmt":"2026-10-05T08:07:16","guid":{"rendered":"https:\/\/amr-promise.fr\/?p=3783"},"modified":"2026-10-05T10:17:34","modified_gmt":"2026-10-05T08:17:34","slug":"francais-prevention-des-infections-et-lutte-contre-lantibioresistance-les-nouveautes-et-ressources-disponibles-en-2026","status":"publish","type":"post","link":"https:\/\/amr-promise.fr\/fr\/francais-prevention-des-infections-et-lutte-contre-lantibioresistance-les-nouveautes-et-ressources-disponibles-en-2026\/","title":{"rendered":"Pr\u00e9vention des infections et lutte contre l&rsquo;antibior\u00e9sistance : les nouveaut\u00e9s et ressources disponibles en 2026"},"content":{"rendered":"<p class=\"wp-block-paragraph\">En 2026, de <strong>nouveaux outils, donn\u00e9es et rapports<\/strong> viennent enrichir les dispositifs de <strong>pr\u00e9vention des infections et de surveillance de l\u2019antibior\u00e9sistance<\/strong>. La Direction g\u00e9n\u00e9rale de la sant\u00e9 (DGS), \u00e0 travers la mission Pr\u00e9vention des infections et de l\u2019antibior\u00e9sistance (PIA), recense ces nouveaut\u00e9s afin de faciliter leur diffusion aupr\u00e8s des professionnels et des acteurs concern\u00e9s.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Vous trouverez ci-dessous <strong>une s\u00e9lection non exhaustive des ressources disponibles, regroup\u00e9es par th\u00e9matique<\/strong> : nouveaut\u00e9s 2026, outils g\u00e9n\u00e9raux, outils de datavisualisation, autres outils disponibles et rapports relatifs \u00e0 la surveillance.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Nouveaut\u00e9s 2026<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Th\u00e9matique<\/th><th>Secteur<\/th><th>Public<\/th><th>Auteur<\/th><th>Liens<\/th><\/tr><\/thead><tbody><tr><td><strong>Pack \u00ab r\u00e9f\u00e9rent en antibioth\u00e9rapie \u00bb<\/strong> : outils pratiques pour mener un programme de BUA efficace et optimal en fonction des ressources. <em>*La certification HAS pr\u00e9voit que les \u00e9tablissements disposent d\u2019un r\u00e9f\u00e9rent en antibioth\u00e9rapie identifi\u00e9 et b\u00e9n\u00e9ficiant d\u2019un temps d\u00e9di\u00e9 adapt\u00e9 \u00e0 ses missions.<\/em><\/td><td>ES<\/td><td>PdS r\u00e9f\u00e9rents, EMA<\/td><td>SPARES<\/td><td>Acc\u00e8s <a href=\"https:\/\/urldefense.com\/v3\/__https:\/www.antibioest.org\/spares\/*pack_referent__;Iw!!FiWPmuqhD5aF3oDTQnc!hOfGUi_ErCwW74TA809gum5e1rEmisAjhIsyYSb379-jyzxA4dKYYLK7GKT4hLwLkY6thW6kNofZvEoUfUGBPDWQly0VtDJsCQ$\" target=\"_blank\" rel=\"noreferrer noopener\">Pack_Referent<\/a><\/td><\/tr><tr><td><strong>T\u00e9moignages patients- antibior\u00e9sistance :<\/strong> la vid\u00e9o courte diffusable en salle d\u2019attente ! Parcours de 3 patients ayant v\u00e9cu une infection caus\u00e9e par une bact\u00e9rie r\u00e9sistante (vid\u00e9o ou podcasts).<\/td><td>ES, ESMS, Ville<\/td><td>PdS<\/td><td>MATIS<\/td><td>Plus d\u2019information <a href=\"https:\/\/urldefense.com\/v3\/__https:\/www.preventioninfection.fr\/temoignages-de-patients-antibioresistance\/__;!!FiWPmuqhD5aF3oDTQnc!l5t5t2fSf52P6dDAXfx4tWttNZpeAMSbWbQhxDWiC4Q5_XgWo42S4y1Sc6H2KB22dZ95fJCnkfBpPX7Byr6WuxDaMTJhPosWBBfCuqBb$\" target=\"_blank\" rel=\"noreferrer noopener\">ici<\/a><\/td><\/tr><tr><td><strong>Kit du patient op\u00e9r\u00e9<\/strong> (4 supports) : information des patients sur la pr\u00e9paration cutan\u00e9e (fiche m\u00e9mo), vid\u00e9o-capsule sur la douche pr\u00e9op\u00e9ratoire, guide sur la d\u00e9pilation pr\u00e9op\u00e9ratoire, aide au suivi de la cicatrice \u00e0 domicile en postop\u00e9ratoire.<\/td><td>ES<\/td><td>PdS, patients<\/td><td>SPICMI<\/td><td>Affiche du kit &#8211; SSP 2026 : <a href=\"https:\/\/urldefense.com\/v3\/__https:\/www.preventioninfection.fr\/securite-des-patients\/__;!!FiWPmuqhD5aF3oDTQnc!kM0qiUQojYMnGatK-YfbhzOuHXdPGfO11t3u97g__g_vcWvVH7dpLYx9d5UOTyTEu6gzklHQ-Bfc0TQq5Q9h-kKgrW610QasptLe$\" target=\"_blank\" rel=\"noreferrer noopener\">acc\u00e8s<\/a><br>Acc\u00e8s au kit\u00a0: <a href=\"https:\/\/urldefense.com\/v3\/__https:\/www.cpias-ile-de-france.fr\/spicmi\/prevention\/supports.php__;!!FiWPmuqhD5aF3oDTQnc!kM0qiUQojYMnGatK-YfbhzOuHXdPGfO11t3u97g__g_vcWvVH7dpLYx9d5UOTyTEu6gzklHQ-Bfc0TQq5Q9h-kKgrW610SkNd4tH$\" target=\"_blank\" rel=\"noreferrer noopener\">supports<\/a><\/td><\/tr><tr><td><strong>Participation des ES \u00e0 la surveillance SPICMI<\/strong> \u2013 actions \u00e0 entreprendre en septembre \/ octobre 2026 :<br>&#8211; prendre contact avec le DIM<br>&#8211; demander l&rsquo;extraction des donn\u00e9es du PMSI<br>&#8211; r\u00e9cup\u00e9rer tous les documents n\u00e9cessaires (cf. site CPias IDF\/Spicmi) et lui transmettre<\/td><td>ES<\/td><td>PdS<\/td><td>SPICMI<\/td><td>Fiche d\u2019aide \u00e0 l\u2019extraction (<a href=\"https:\/\/urldefense.com\/v3\/__https:\/www.cpias-ile-de-france.fr\/spicmi\/surveillance\/fiche-extraction-UB.pdf__;!!FiWPmuqhD5aF3oDTQnc!kM0qiUQojYMnGatK-YfbhzOuHXdPGfO11t3u97g__g_vcWvVH7dpLYx9d5UOTyTEu6gzklHQ-Bfc0TQq5Q9h-kKgrW610aBjiYos$\" target=\"_blank\" rel=\"noreferrer noopener\">Fiche UB <\/a>, <a href=\"https:\/\/urldefense.com\/v3\/__https:\/www.cpias-ile-de-france.fr\/spicmi\/surveillance\/fiche-extraction-PB.pdf__;!!FiWPmuqhD5aF3oDTQnc!kM0qiUQojYMnGatK-YfbhzOuHXdPGfO11t3u97g__g_vcWvVH7dpLYx9d5UOTyTEu6gzklHQ-Bfc0TQq5Q9h-kKgrW610Tzp1fUF$\" target=\"_blank\" rel=\"noreferrer noopener\">Fiche PB <\/a>)<br>Th\u00e9saurus (<a href=\"https:\/\/urldefense.com\/v3\/__https:\/www.cpias-ile-de-france.fr\/spicmi\/surveillance\/thesaurus-spicmi-2026.xlsx__;!!FiWPmuqhD5aF3oDTQnc!kM0qiUQojYMnGatK-YfbhzOuHXdPGfO11t3u97g__g_vcWvVH7dpLYx9d5UOTyTEu6gzklHQ-Bfc0TQq5Q9h-kKgrW610QauhFHK$\" target=\"_blank\" rel=\"noreferrer noopener\">Ici<\/a>)<br>Fichier type Excel (<a href=\"https:\/\/urldefense.com\/v3\/__https:\/www.cpias-ile-de-france.fr\/spicmi\/surveillance\/fichier-unique-importation-entete-sf2026.zip__;!!FiWPmuqhD5aF3oDTQnc!kM0qiUQojYMnGatK-YfbhzOuHXdPGfO11t3u97g__g_vcWvVH7dpLYx9d5UOTyTEu6gzklHQ-Bfc0TQq5Q9h-kKgrW610b_lC8rQ$\" target=\"_blank\" rel=\"noreferrer noopener\">Ici<\/a>)<\/td><\/tr><tr><td><strong>Flyer de promotion du signalement des IAS en soins de ville<\/strong><\/td><td>Ville, ESMS, ES<\/td><td>PdS<\/td><td>PRIMO<\/td><td>Acc\u00e8s <a href=\"https:\/\/urldefense.com\/v3\/__https:\/antibioresistance.fr\/images\/PCI\/REPIA_PRIMO_IAS2026.pdf__;!!E0Ahi1ckbONv5w!4dIPzdB-50zrq1KgFzVWLvif0PpKOof1E8uT9BF98FbbtS4TAntJjsqwHDXm9TG29_wC1aEcGLOugyne7Uso8pbktLIHyTHO6mgi6ufD$\" target=\"_blank\" rel=\"noreferrer noopener\">Flyer IAS<\/a><\/td><\/tr><tr><td><strong>Recensement des outils sp\u00e9cifiques aux soins de ville pour pr\u00e9venir la transmission des infections<\/strong><\/td><td>Ville<\/td><td>PdS ville<\/td><td>PRIMO, MATIS, CPias<\/td><td>Acc\u00e8s <a href=\"https:\/\/urldefense.com\/v3\/__https:\/antibioresistance.fr\/images\/PCI\/VILLE-PREVENTION\/Recensement_outils_PCI_ville.pdf__;!!E0Ahi1ckbONv5w!4dIPzdB-50zrq1KgFzVWLvif0PpKOof1E8uT9BF98FbbtS4TAntJjsqwHDXm9TG29_wC1aEcGLOugyne7Uso8pbktLIHyTHO6hHLRvNf$\" target=\"_blank\" rel=\"noreferrer noopener\">Listing<\/a><\/td><\/tr><tr><td><strong>Biblioth\u00e8que interactive de donn\u00e9es SHS<\/strong> permettant d&rsquo;explorer rapidement les r\u00e9sultats de la litt\u00e9rature scientifique consacr\u00e9e aux d\u00e9terminants de la prescription, de la d\u00e9livrance et de la consommation des antibiotiques<\/td><td>Ville, ESMS, ES<\/td><td>PdS<\/td><td>PRIMO<\/td><td>Acc\u00e8s <a href=\"https:\/\/urldefense.com\/v3\/__https:\/antibioresistance.fr\/bon-usage-des-antibiotiques\/base-de-donnees-shs__;!!E0Ahi1ckbONv5w!4dIPzdB-50zrq1KgFzVWLvif0PpKOof1E8uT9BF98FbbtS4TAntJjsqwHDXm9TG29_wC1aEcGLOugyne7Uso8pbktLIHyTHO6iDt05na$\" target=\"_blank\" rel=\"noreferrer noopener\">biblioth\u00e8que donn\u00e9es SHS<\/a><\/td><\/tr><tr><td><strong>Datavisualisation des consommations de PHA en EHPAD<\/strong>, et \u00e0 venir les indicateurs de la r\u00e9sistance bact\u00e9rienne<\/td><td>ESMS<\/td><td>PdS<\/td><td>PRIMO<\/td><td>Acc\u00e8s <a href=\"https:\/\/urldefense.com\/v3\/__https:\/missionprimo.shinyapps.io\/DV-PRIMO\/__;!!E0Ahi1ckbONv5w!4dIPzdB-50zrq1KgFzVWLvif0PpKOof1E8uT9BF98FbbtS4TAntJjsqwHDXm9TG29_wC1aEcGLOugyne7Uso8pbktLIHyTHO6kN0USJX$\" target=\"_blank\" rel=\"noreferrer noopener\">Datavisualisation<\/a><\/td><\/tr><tr><td><strong>M\u00e9mo Dento, aide au diagnostic et \u00e0 la prise en charge des urgences dentaires<\/strong> pour les m\u00e9decins g\u00e9n\u00e9ralistes et les pharmaciens officinaux<\/td><td>Ville, ESMS<\/td><td>PdS<\/td><td>PRIMO, UFSBD<\/td><td>Acc\u00e8s <a href=\"https:\/\/urldefense.com\/v3\/__https:\/memodento.fr\/__;!!FiWPmuqhD5aF3oDTQnc!huAtC_I-GYwAbN414vj3NdE70c4ZJsl4EZ2FqjADb0mjEnyLi4_sV2gwEoSKEjLY7LsCyTbFiBS3cgnCA-EHIDVqIkZzkd9P$\" target=\"_blank\" rel=\"noreferrer noopener\">M\u00e9mo Dento<\/a><\/td><\/tr><tr><td><strong>\u00ab\u00a0Le saviez-vous\u00a0\u00bb<\/strong>, fiche \u00e0 destination des m\u00e9decins g\u00e9n\u00e9ralistes pour d\u00e9construire des id\u00e9es pr\u00e9con\u00e7ues sur l&rsquo;attente des patients, le risque de complication<\/td><td>Ville, ESMS<\/td><td>PdS<\/td><td>PRIMO, Antibioclic<\/td><td>Tome 1 pr\u00e9vu en octobre<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">Outils g\u00e9n\u00e9raux<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Th\u00e9matique<\/th><th>Public<\/th><th>Auteur<\/th><th>Liens<\/th><\/tr><\/thead><tbody><tr><td>Bon usage des antibiotiques<\/td><td>Grand public<\/td><td>Minist\u00e8re de la sant\u00e9 et PRIMO<\/td><td>Acc\u00e8s <a href=\"https:\/\/www.sante.fr\/antibiomalin-pour-savoir-comment-bien-utiliser-les-antibiotiques\" target=\"_blank\" rel=\"noreferrer noopener\">AntibioMalin<\/a><\/td><\/tr><tr><td>Pr\u00e9vention des infections<\/td><td>Grand public, Education Nationale, \u00e9tudiants en sant\u00e9<\/td><td>CHU Nice<\/td><td>Acc\u00e8s <a href=\"https:\/\/e-bug.eu\/fr-fr\" target=\"_blank\" rel=\"noreferrer noopener\">e-bug<\/a><\/td><\/tr><tr><td>Boite \u00e0 outils<\/td><td>PdS, \u00e9quipe soignante<\/td><td>PRIMO<\/td><td>Acc\u00e8s <a href=\"https:\/\/antibioresistance.fr\/boite-a-outils\" target=\"_blank\" rel=\"noreferrer noopener\">site Primo<\/a><\/td><\/tr><tr><td>Focus sur le portail documentaire du RePIA<\/td><td>Grand public, PdS, ARS<\/td><td>MATIS<\/td><td>Acc\u00e8s <a href=\"https:\/\/www.youtube.com\/watch?v=lXGCxvZCkpE\" target=\"_blank\" rel=\"noreferrer noopener\">tutoriel<\/a><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">Outils de datavisualisation<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Th\u00e9matique<\/th><th>P\u00e9rim\u00e8tre<\/th><th>Auteur<\/th><th>Liens<\/th><\/tr><\/thead><tbody><tr><td>Suivi de la <strong>pertinence de prescription des ATB en ville<\/strong><\/td><td>France<\/td><td>DREES<\/td><td><br><a href=\"https:\/\/drees.shinyapps.io\/prescription-antibios-MG\/\" target=\"_blank\" rel=\"noreferrer noopener\">Datavisualisation<\/a><\/td><\/tr><tr><td>Suivi de la <strong>consommation et pertinence des ATB en ville et ESMS<\/strong><\/td><td>France<\/td><td>PRIMO<\/td><td><a href=\"https:\/\/missionprimo.shinyapps.io\/DV-PRIMO\/\" target=\"_blank\" rel=\"noreferrer noopener\">Datavisualisation<\/a><\/td><\/tr><tr><td>Suivi en temps r\u00e9el <strong>des r\u00e9sistances bact\u00e9riennes en ville et en Ehpad<\/strong>, au niveau national, r\u00e9gional, d\u00e9partemental et EPCI<\/td><td>France<\/td><td>PRIMO<\/td><td><a href=\"https:\/\/urldefense.com\/v3\/__https:\/medqualville.antibioresistance.fr\/__;!!E0Ahi1ckbONv5w!942kvP7sbrD5UieGeT2oKON-ri5eeJK3qDaGrfLkEsFuXO3GDPLMW5Rfl5_v4fY2FIzRMwmeMKF7Xyj22EMmNL-d74S9lbs$\" target=\"_blank\" rel=\"noreferrer noopener\">E-outil MedQual-Ville<\/a><\/td><\/tr><tr><td>Suivi de <strong>la consommation des ATB et antifongiques<\/strong>, r\u00e9sistance aux antibiotiques en ES<\/td><td>France<\/td><td>SPARES<\/td><td><a href=\"https:\/\/www.consores.fr\/visiteur\/analyse\/\" target=\"_blank\" rel=\"noreferrer noopener\">Datavisualisation<\/a><\/td><\/tr><tr><td>Portail d\u2019open data \u2013 filtre possible sur des th\u00e9matiques PIA<\/td><td>France<\/td><td>Sant\u00e9 Publique France<\/td><td>Acc\u00e8s <a href=\"https:\/\/odisse.santepubliquefrance.fr\/pages\/accueil\/?flg=fr-fr\" target=\"_blank\" rel=\"noreferrer noopener\">Odiss\u00e9<\/a><\/td><\/tr><tr><td>Syst\u00e8me de surveillance de la consommation et de la r\u00e9sistance aux antimicrobiens<\/td><td>Monde<\/td><td>OMS<\/td><td>Acc\u00e8s <a href=\"https:\/\/worldhealthorg.shinyapps.io\/glass-dashboard\/_w_df14a51971d2446ebb3ffa110328919a\/#!\/home\" target=\"_blank\" rel=\"noreferrer noopener\">GLASS<\/a><\/td><\/tr><tr><td>Suivi de la r\u00e9sistance aux antimicrobiens (approche One Health)<\/td><td>Monde<\/td><td>Quadripartite<\/td><td>Acc\u00e8s <a href=\"https:\/\/amrcountryprogress.org\/\" target=\"_blank\" rel=\"noreferrer noopener\">TrACSS<\/a>\u00a0<\/td><\/tr><tr><td>Suivi des infections, des agents pathog\u00e8nes et de la r\u00e9sistance aux antimicrobiens<\/td><td>Monde<\/td><td>University of Oxford<\/td><td>Acc\u00e8s <a href=\"https:\/\/vizhub.healthdata.org\/microbe\/\" target=\"_blank\" rel=\"noreferrer noopener\">MICROBE<\/a><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">Autres outils disponibles<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Th\u00e9matique<\/th><th>Secteur<\/th><th>Public<\/th><th>Auteur<\/th><th>Liens<\/th><\/tr><\/thead><tbody><tr><td>Evaluation du risque infectieux<\/td><td>ESMS<\/td><td>PdS, \u00e9quipe soignante<\/td><td>Groupe inter-CPIas<\/td><td>Acc\u00e8s <a href=\"https:\/\/www.cpiasbfc.fr\/trame.php?page=8\" target=\"_blank\" rel=\"noreferrer noopener\">DAMRI<\/a><\/td><\/tr><tr><td>Courbes \u00e9pid\u00e9miques<\/td><td>ESMS, ES<\/td><td>PdS en hygi\u00e8ne<\/td><td>PRIMO<\/td><td>Acc\u00e8s <a href=\"https:\/\/urldefense.com\/v3\/__https:\/eur03.safelinks.protection.outlook.com\/?url=https*3A*2F*2Fantibioresistance.fr*2Fimages*2FPCI*2FESMS*2520-*2520PREVENTION*2FCourbe_Epidemique_ESMS_V2024_2.xlsx&amp;data=05*7C02*7Ccharlotte.moreau*40chu-lyon.fr*7C8a54d3ceab4049a47bfa08de28da804e*7C0d2e3400657d4eb3817b62ee9d5f5281*7C0*7C0*7C638993116217776794*7CUnknown*7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ*3D*3D*7C0*7C*7C*7C&amp;sdata=4Mkqbj5KzlgY9c7eR21dBx9F97fjk0zYgRAVf5vHWO4*3D&amp;reserved=0__;JSUlJSUlJSUlJSUlJSUlJSUlJSUlJSUlJSU!!FiWPmuqhD5aF3oDTQnc!mXL80HhkY7ASSKDAcPdKfQzdSZJ1Vk-_cnbpndAiT-eyhfIXUPJdmK7aShr4TDMnZoOZbrzvcMrGdOOtTIhC8DWAgIouVMeYOglKBi8$\" target=\"_blank\" rel=\"noreferrer noopener\">outil Excel<\/a><\/td><\/tr><tr><td>Gestion des \u00e9pid\u00e9mies d\u2019IRA ou de GEA<\/td><td>ESMS<\/td><td>PdS, \u00e9quipe soignante<\/td><td>PRIMO<\/td><td>Acc\u00e8s <a href=\"https:\/\/urldefense.com\/v3\/__https:\/antibioresistance.fr\/images\/PCI\/ESMS*20-*20PREVENTION\/Checklist_IRA_GEA_V14.docx__;JSU!!E0Ahi1ckbONv5w!_OWGc1dZy2zVBJ1TLyOLMTnBzeUruu8aBwGpTxPvKdmgd06oVkNgrehCty9ECKn9IJIV1RPuZZR8oS2ylJAX_oC66lKt6iCrUw$\" target=\"_blank\" rel=\"noreferrer noopener\">Checklist EPID\u2019ESMS\u00a0<\/a><\/td><\/tr><tr><td>Recommandations sur le port d\u2019EPI \u2013 r\u00e9sident atteint d\u2019IRA<\/td><td>ESMS<\/td><td>PdS, \u00e9quipe soignante<\/td><td>PRIMO<\/td><td><br>Acc\u00e8s <a href=\"https:\/\/antibioresistance.fr\/images\/PCI\/ESMS%20-%20PREVENTION\/PRIMO_Recommandations_EPI_gestion_IRA_ESMS.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">affiche<\/a><\/td><\/tr><tr><td>Evaluation de la qualit\u00e9 des ESMS<\/td><td>ESMS<\/td><td>PdS, \u00e9quipe soignante<\/td><td>PRIMO<\/td><td><br><a href=\"https:\/\/antibioresistance.fr\/images\/PCI\/ESMS%20-%20PREVENTION\/EvaluationESSMS_V2025.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Guide d\u2019appui<\/a> pour atteindre l\u2019objectif 3.7 sur le risque infectieux (manuel HAS)<\/td><\/tr><tr><td>Promotion et utilisation des produits hydro-alcooliques en ESMS<\/td><td>ESMS<\/td><td>PdS, \u00e9quipe soignante<\/td><td>PRIMO<\/td><td><br>Auto\u00e9valuation <a href=\"https:\/\/antibioresistance.fr\/images\/PCI\/Audit-Enquete_EMS\/Notice_utilisation_outil_FHACILE.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">FHA\u2019CILE<\/a> , retrouvez la <a href=\"https:\/\/urldefense.com\/v3\/__https:\/antibioresistance.fr\/images\/PCI\/Audit-Enquete_EMS\/Notice_utilisation_outil_FHACILE.pdf__;!!E0Ahi1ckbONv5w!4dIPzdB-50zrq1KgFzVWLvif0PpKOof1E8uT9BF98FbbtS4TAntJjsqwHDXm9TG29_wC1aEcGLOugyne7Uso8pbktLIHyTHO6imU0f-W$\" target=\"_blank\" rel=\"noreferrer noopener\">notice d\u2019utilisation<\/a> de l\u2019outil<\/td><\/tr><tr><td>Hygi\u00e8ne respiratoire des professionnels<\/td><td>ES<\/td><td>PdS, \u00e9quipe soignante<\/td><td>MATIS<\/td><td>Acc\u00e8s <a href=\"https:\/\/www.preventioninfection.fr\/actualites\/le-masque-peut-penaliser-la-communication\/\" target=\"_blank\" rel=\"noreferrer noopener\">Respi\u2019quizz \u00e9quipe<\/a><\/td><\/tr><tr><td>Gestion quotidienne des risques infectieux<\/td><td>ES<\/td><td>PdS, \u00e9quipe soignante<\/td><td>MATIS<\/td><td>Acc\u00e8s <a href=\"https:\/\/www.preventioninfection.fr\/bug-control\/\" target=\"_blank\" rel=\"noreferrer noopener\">Bug.control<\/a><\/td><\/tr><tr><td>Outil national d&rsquo;\u00e9valuation de l&rsquo;antibioprophylaxie : audit ATBP 2025<\/td><td>ES<\/td><td>PdS, \u00e9quipe soignante<\/td><td>SPICMI<\/td><td>Acc\u00e8s <a href=\"https:\/\/www.cpias-ile-de-france.fr\/spicmi\/prevention\/audit-atbp.php\" target=\"_blank\" rel=\"noreferrer noopener\">plateforme<\/a> et <a href=\"https:\/\/www.cpias-ile-de-france.fr\/spicmi\/webinaire\/Dia-webinaire-230925.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">support<\/a> de pr\u00e9sentation<\/td><\/tr><tr><td>Evaluation des pratiques : pertinence des prescriptions ATB<\/td><td>ES<\/td><td>PdS,<\/td><td>SPARES<\/td><td>Acc\u00e8s <a href=\"https:\/\/documentation-forum.preventioninfection.fr\/Record.htm?idlist=1&amp;record=19136331124919545139\" target=\"_blank\" rel=\"noreferrer noopener\">Quick\u00a0\u00c9VAL Antibio<\/a><\/td><\/tr><tr><td>Pertinence de l\u2019antibioth\u00e9rapie<\/td><td>ES<\/td><td>PdS<\/td><td>SPARES<\/td><td>Acc\u00e8s <a href=\"https:\/\/www.preventioninfection.fr\/actualites\/spares-fiche-conseil-pertinence-des-antibiotherapies\/\" target=\"_blank\" rel=\"noreferrer noopener\">fiche-conseil<\/a><\/td><\/tr><tr><td>Kit d\u2019outils BUA (nouvelles ressources r\u00e9guli\u00e8res et actualis\u00e9es) pour accompagner les d\u00e9marches de BUA.<\/td><td>ES<\/td><td>PdS<\/td><td>SPARES<\/td><td>Acc\u00e8s <a href=\"https:\/\/documentation-forum.preventioninfection.fr\/Record.htm?idlist=1&amp;record=19136295124919544779\" target=\"_blank\" rel=\"noreferrer noopener\">kit<\/a><\/td><\/tr><tr><td>Choix de la voie d\u2019administration d\u2019un anti-infectieux<\/td><td>ES<\/td><td>PdS<\/td><td>SPARES, PRIMO, SPILF, SFPC<\/td><td>Acc\u00e8s <a href=\"https:\/\/urldefense.com\/v3\/__https:\/www.antibioest.org\/spares\/*fiche_pratique_voie_administration__;Iw!!FiWPmuqhD5aF3oDTQnc!hOfGUi_ErCwW74TA809gum5e1rEmisAjhIsyYSb379-jyzxA4dKYYLK7GKT4hLwLkY6thW6kNofZvEoUfUGBPDWQly0c4jaqWg$\" target=\"_blank\" rel=\"noreferrer noopener\">fiche<\/a><\/td><\/tr><tr><td><em>Clostridio\u00efdes difficile<\/em> : prise en charge<\/td><td>Ville<\/td><td>PdS<\/td><td>PRIMO<\/td><td>Acc\u00e8s <a href=\"https:\/\/antibioresistance.fr\/images\/BUA\/REPIA_PRIMO_Clostridioides%20difficile_V6.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">fiche<\/a><\/td><\/tr><tr><td>Pneumonies aig\u00fces communautaires<\/td><td>Ville<\/td><td>PdS<\/td><td>PRIMO<\/td><td>Acc\u00e8s <a href=\"https:\/\/urldefense.com\/v3\/__https:\/view.genially.com\/68823f3b4cbd1757972ab4f6__;!!E0Ahi1ckbONv5w!_OWGc1dZy2zVBJ1TLyOLMTnBzeUruu8aBwGpTxPvKdmgd06oVkNgrehCty9ECKn9IJIV1RPuZZR8oS2ylJAX_oC66lKQg-IQqg$\" target=\"_blank\" rel=\"noreferrer noopener\">quiz<\/a> et <a href=\"https:\/\/urldefense.com\/v3\/__https:\/app.questionnaireweb.com\/f\/334074\/4qGwY7DPCAHtkJKkxc47bf__;!!E0Ahi1ckbONv5w!_OWGc1dZy2zVBJ1TLyOLMTnBzeUruu8aBwGpTxPvKdmgd06oVkNgrehCty9ECKn9IJIV1RPuZZR8oS2ylJAX_oC66lKySjaPLg$\" target=\"_blank\" rel=\"noreferrer noopener\">cas clinique<\/a><\/td><\/tr><tr><td>Pneumonies d\u2019inhalation<\/td><td>Ville<\/td><td>PdS<\/td><td>PRIMO<\/td><td>Acc\u00e8s <a href=\"https:\/\/urldefense.com\/v3\/__https:\/view.genially.com\/68c2c91f1cfe86080940afd2__;!!E0Ahi1ckbONv5w!_OWGc1dZy2zVBJ1TLyOLMTnBzeUruu8aBwGpTxPvKdmgd06oVkNgrehCty9ECKn9IJIV1RPuZZR8oS2ylJAX_oC66lLI0lSRcw$\" target=\"_blank\" rel=\"noreferrer noopener\">quiz<\/a> et <a href=\"https:\/\/urldefense.com\/v3\/__https:\/app.questionnaireweb.com\/f\/334078\/4qGwYFueasC9D36VgJrXQi__;!!E0Ahi1ckbONv5w!_OWGc1dZy2zVBJ1TLyOLMTnBzeUruu8aBwGpTxPvKdmgd06oVkNgrehCty9ECKn9IJIV1RPuZZR8oS2ylJAX_oC66lKv144zUQ$\" target=\"_blank\" rel=\"noreferrer noopener\">cas clinique<\/a><\/td><\/tr><tr><td>Carnets de jeux vaccination antigrippale \/ Approche One-Health<\/td><td>Ville, ES, ESMS<\/td><td>Grand public, PdS<\/td><td>ARS, OMEDIT et CPias Occitanie<\/td><td>Acc\u00e8s <a href=\"https:\/\/cpias-occitanie.fr\/actualites\/le-carnet-pour-combattre-la-grippe\/\" target=\"_blank\" rel=\"noreferrer noopener\">carnet &#8211; Cpias<\/a><\/td><\/tr><tr><td>Pages Grand public MATIS R\u00e9PIA : mieux comprendre comment \u00e9viter les infections et l\u2019antibior\u00e9sistance (travaill\u00e9es avec des sp\u00e9cialistes de la communication et des sciences humaines)<\/td><td>Ville, ES, ESMS<\/td><td>Grand public<\/td><td>MATIS R\u00e9PIA<\/td><td>Acc\u00e8s <a href=\"https:\/\/urldefense.com\/v3\/__https:\/www.preventioninfection.fr\/comprendre-les-infections-et-les-eviter\/__;!!FiWPmuqhD5aF3oDTQnc!l5t5t2fSf52P6dDAXfx4tWttNZpeAMSbWbQhxDWiC4Q5_XgWo42S4y1Sc6H2KB22dZ95fJCnkfBpPX7Byr6WuxDaMTJhPosWBN-MF-Fy$\" target=\"_blank\" rel=\"noreferrer noopener\">Comprendre les Infections et les \u00c9viter<\/a>\u00a0; <a href=\"https:\/\/urldefense.com\/v3\/__https:\/www.preventioninfection.fr\/comprendre-les-antibiotiques-et-l-antibioresistance\/__;!!FiWPmuqhD5aF3oDTQnc!l5t5t2fSf52P6dDAXfx4tWttNZpeAMSbWbQhxDWiC4Q5_XgWo42S4y1Sc6H2KB22dZ95fJCnkfBpPX7Byr6WuxDaMTJhPosWBK6SG57_$\" target=\"_blank\" rel=\"noreferrer noopener\">les Antibiotiques et l&rsquo;Antibior\u00e9sistance<\/a>\u00a0; <a href=\"https:\/\/urldefense.com\/v3\/__https:\/www.preventioninfection.fr\/tous-les-acteurs-de-la-prevention-des-infections\/__;!!FiWPmuqhD5aF3oDTQnc!l5t5t2fSf52P6dDAXfx4tWttNZpeAMSbWbQhxDWiC4Q5_XgWo42S4y1Sc6H2KB22dZ95fJCnkfBpPX7Byr6WuxDaMTJhPosWBOs3dxEu$\" target=\"_blank\" rel=\"noreferrer noopener\">acteurs de la Pr\u00e9vention des Infections<\/a><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">Rapports relatifs \u00e0 la surveillance<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Th\u00e9matique<\/th><th>Support<\/th><th>Secteur<\/th><th>Public<\/th><th>Auteur<\/th><th>Liens<\/th><\/tr><\/thead><tbody><tr><td>Surveillance du <strong>risque infectieux en chirurgie et m\u00e9decine interventionnelle<\/strong><\/td><td>Protocole 2025, R\u00e9sultats 2024<\/td><td>ES<\/td><td>PdS<\/td><td>SPICMI<\/td><td>Acc\u00e8s <a href=\"https:\/\/www.cpias-ile-de-france.fr\/spicmi\/surveillance\/protocole-surveillance-2025.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">protocole<\/a> ; Acc\u00e8s <a href=\"https:\/\/www.cpias-ile-de-france.fr\/spicmi\/surveillance\/tdb-surveillance-2024-nov2025.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">r\u00e9sultats<\/a><\/td><\/tr><tr><td>Surveillance de la <strong>r\u00e9sistance bact\u00e9rienne en soins de ville et en EHPAD<\/strong> : <em>antibior\u00e9sistance ; indicateurs de la strat\u00e9gie nationale ; r\u00e9sistance aux antibiotiques \u00e0 vis\u00e9e urinaire<\/em><\/td><td>Rapports r\u00e9gionaux<\/td><td>Ville<\/td><td>ARS, PdS<\/td><td>PRIMO<\/td><td>Acc\u00e8s <a href=\"https:\/\/antibioresistance.fr\/en-region\/rapports-surveillance-ratb\" target=\"_blank\" rel=\"noreferrer noopener\">site<\/a><\/td><\/tr><tr><td>Surveillance de la <strong>consommation des antibiotiques, des antifongiques et des r\u00e9sistances bact\u00e9riennes en \u00e9tablissement de sant\u00e9<\/strong><\/td><td>R\u00e9sultats 2024<\/td><td>ES<\/td><td>ARS, PdS<\/td><td>SPARES<\/td><td>Acc\u00e8s <a href=\"https:\/\/www.santepubliquefrance.fr\/infections-associees-aux-soins\/rapportsynthese\/surveillance-de-la-consommation-des-antibiotiques-des-antifongiques-et-des-resistances-bacteriennes\" target=\"_blank\" rel=\"noreferrer noopener\">rapport<\/a><\/td><\/tr><tr><td>Surveillance des <strong>consommations d\u2019antibiotiques et d\u2019antifongiques en EHPAD avec PUI<\/strong><\/td><td>R\u00e9sultats 2024<\/td><td>ESMS<\/td><td>ARS, PdS<\/td><td>SPARES<\/td><td>Acc\u00e8s <a href=\"https:\/\/www.santepubliquefrance.fr\/infections-associees-aux-soins\/rapportsynthese\/surveillance-de-la-consommation-dantibiotiques-et-dantifongiques-en-etablissements-dhebergement-pour\" target=\"_blank\" rel=\"noreferrer noopener\">rapport<\/a><\/td><\/tr><tr><td>Surveillance des <strong>infections associ\u00e9es aux dispositifs invasifs<\/strong><\/td><td>R\u00e9sultats 2025 et \u00e9volution 2023-2025.<\/td><td>ES, ESMS, Ville<\/td><td>ARS, PdS<\/td><td>SPIADI<\/td><td>Acc\u00e8s <a href=\"https:\/\/partage.santepubliquefrance.fr\/public\/folder\/vvexfrv1d0c9r-rtf5embw\/DMI-26-D-0411\/DMI-26-D-0411_publication_rapport%20SurvDIV_%20SPI.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">rapport SurvDIV<\/a> et <a href=\"https:\/\/partage.santepubliquefrance.fr\/public\/folder\/vvexfrv1d0c9r-rtf5embw\/DMI-26-D-0411\/DMI-26-D-0411_publication_rapport%20NatOberva4_.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">rapport NatOberva4<\/a><\/td><\/tr><tr><td>Surveillance de la <strong>r\u00e9sistance bact\u00e9rienne aux antibiotiques en soins de ville et en EHPAD<\/strong><\/td><td>R\u00e9sultats 2024<\/td><td>ESMS, Ville<\/td><td>ARS, PdS<\/td><td>PRIMO<\/td><td>Acc\u00e8s <a href=\"https:\/\/antibioresistance.fr\/images\/PUBLICATIONS\/RAPPORTS_PRIMO\/RAPPORT-PRIMO-DONNEES2024-SPF-MARS2026.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Surveillance<\/a><\/td><\/tr><\/tbody><\/table><\/figure>","protected":false},"excerpt":{"rendered":"<p>En 2026, de nouveaux outils, donn\u00e9es et rapports viennent enrichir les dispositifs de pr\u00e9vention des infections et de surveillance de l\u2019antibior\u00e9sistance. La Direction g\u00e9n\u00e9rale de la sant\u00e9 (DGS), \u00e0 travers la mission Pr\u00e9vention des infections et de l\u2019antibior\u00e9sistance (PIA), recense ces nouveaut\u00e9s afin de faciliter leur diffusion aupr\u00e8s des professionnels et des acteurs concern\u00e9s. Vous trouverez ci-dessous une s\u00e9lection non exhaustive des ressources disponibles, regroup\u00e9es par th\u00e9matique : nouveaut\u00e9s 2026,&#8230;<\/p>\n<p> <a class=\"continue-reading-link\" href=\"https:\/\/amr-promise.fr\/fr\/francais-prevention-des-infections-et-lutte-contre-lantibioresistance-les-nouveautes-et-ressources-disponibles-en-2026\/\"><span>Lire plus \/ Read more<\/span><i class=\"crycon-right-dir\"><\/i><\/a> <\/p>\n","protected":false},"author":2354,"featured_media":3786,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_members_access_role":[],"_members_access_error":""},"categories":[1],"tags":[],"class_list":["post-3783","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/amr-promise.fr\/fr\/wp-json\/wp\/v2\/posts\/3783","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/amr-promise.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/amr-promise.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/amr-promise.fr\/fr\/wp-json\/wp\/v2\/users\/2354"}],"replies":[{"embeddable":true,"href":"https:\/\/amr-promise.fr\/fr\/wp-json\/wp\/v2\/comments?post=3783"}],"version-history":[{"count":5,"href":"https:\/\/amr-promise.fr\/fr\/wp-json\/wp\/v2\/posts\/3783\/revisions"}],"predecessor-version":[{"id":3802,"href":"https:\/\/amr-promise.fr\/fr\/wp-json\/wp\/v2\/posts\/3783\/revisions\/3802"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/amr-promise.fr\/fr\/wp-json\/wp\/v2\/media\/3786"}],"wp:attachment":[{"href":"https:\/\/amr-promise.fr\/fr\/wp-json\/wp\/v2\/media?parent=3783"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/amr-promise.fr\/fr\/wp-json\/wp\/v2\/categories?post=3783"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/amr-promise.fr\/fr\/wp-json\/wp\/v2\/tags?post=3783"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}